INmune Bio News - INMB

Company Name	Stock Ticker Symbol	Market	Type
INmune Bio Inc	INMB	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.48	4.73%	10.62	17:26:51

Open Price	Low Price	High Price	Close Price	Prev Close
10.32	9.88	10.73	10.62	10.14

more quote information »

Recent News

Date	Time	Source	Heading
4/23/2024	08:00	GLOBE	INmune Bio Inc. Announces 24-Month Stability Validation of..
4/22/2024	08:00	GLOBE	INmune Bio Inc. Raises Approximately $4.8 Million in Gross..
4/08/2024	08:00	GLOBE	INmune Bio Inc. Presents Data on INB03’s Role as an Immune..
3/28/2024	16:01	GLOBE	INmune Bio Inc. Announces Year End 2023 Results and Provides..
3/26/2024	16:01	GLOBE	INmune Bio Inc. to Report Fourth Quarter 2023 Financial..
3/13/2024	08:00	GLOBE	INmune Bio CSO and Co-Founder Mark Lowdell, Ph.D. Receives..
3/05/2024	08:00	GLOBE	INmune Bio Reports Significant EEG Improvement in..
2/12/2024	09:00	GLOBE	INmune Bio to Participate in the Oppenheimer 34th Annual..
2/06/2024	09:00	GLOBE	INmune Bio to Participate in Baird’s Biotech Discovery..
1/30/2024	08:02	EDGAR2	Form 8-K - Current report
1/30/2024	08:00	GLOBE	INmune Bio Announces FDA Removal of Clinical Hold for..
1/16/2024	08:30	GLOBE	ELEVAI Labs, Inc. Acquires Worldwide License Agreement for..
1/02/2024	16:00	EDGAR2	Form 8-K - Current report
1/02/2024	08:00	GLOBE	INmune Bio Announces First Patient Dosed in a Phase 1/2..
12/18/2023	16:15	EDGAR2	Form 8-K - Current report
12/18/2023	16:05	EDGAR2	Form 8-A12B/A - Registration of securities [Section 12(b)]:..
12/18/2023	16:01	EDGAR2	Form 8-K - Current report
12/18/2023	16:01	GLOBE	INmune Bio Provides Update Regarding Global Alzheimer’s..
11/29/2023	16:00	EDGAR2	Form 8-K - Current report
11/29/2023	08:00	GLOBE	INmune Bio Inc. Demonstrates that INB03 Enhances the Uptake..
11/27/2023	16:00	EDGAR2	Form 8-K - Current report
11/27/2023	08:00	GLOBE	INmune Bio Receives EMA’s Authorization in France and Spain..
11/15/2023	16:13	EDGAR2	Form 8-K - Current report
11/15/2023	09:00	GLOBE	INmune Bio Inc. Announces Expansion of Phase II Clinical..
11/13/2023	11:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/01/2023	16:13	EDGAR2	Form 8-K - Current report
11/01/2023	16:10	GLOBE	INmune Bio Inc. Announces Third Quarter 2023 Results and..
11/01/2023	16:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/31/2023	16:25	EDGAR2	Form 8-K - Current report
10/31/2023	08:00	GLOBE	INmune Bio Inc. Patent Claims Covering INB16 Cell Line and..
10/30/2023	09:07	GLOBE	INmune Bio Inc. Presents Preclinical Data at SITC 2023..
10/17/2023	08:00	GLOBE	INmune Bio Inc. Presents New Biomarker and Feasibility Data..
10/16/2023	09:00	GLOBE	INmune Bio Inc. to Report Third Quarter 2023 Financial..
9/07/2023	09:10	EDGAR2	Form 8-K - Current report
9/07/2023	09:00	GLOBE	INmune Bio Inc. to Present at Baird Global Healthcare..
9/05/2023	16:00	EDGAR2	Form 8-K - Current report
9/05/2023	08:00	GLOBE	INmune Bio Inc. Announces Approval of Clinical Trial..
8/16/2023	16:41	EDGAR2	Form 8-K - Current report
8/16/2023	16:39	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
8/08/2023	16:01	EDGAR2	Form 8-K - Current report
8/07/2023	16:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/2023	16:00	GLOBE	INmune Bio Inc. Announces Second Quarter 2023 Results and..
8/02/2023	06:02	EDGAR2	Form 8-K - Current report
8/01/2023	08:00	GLOBE	INmune Bio Inc. to Present at the BTIG Virtual ..
7/31/2023	08:00	GLOBE	INmune Bio, Inc. to Report Second Quarter 2023 Financial..
7/27/2023	16:43	EDGAR2	Form 8-K - Current report
7/14/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/12/2023	16:00	EDGAR2	Form 8-K - Current report
7/12/2023	13:23	EDGAR2	Form 144 - Report of proposed sale of securities
7/12/2023	08:00	GLOBE	INmune Bio Inc. to Deliver Keynote Talk at 5th World Aging..